UCB's Global Corporate Website

This section is intended for media and financial analysts

Our Shareholders

Since 13 March 2014, UCB’s capital amounts to € 583 516 974, divided in 194 505 658 ordinary shares with no nominal value.

The main shareholder of UCB is Financière de Tubize SA, a Belgian company listed on Euronext Brussels. The latest shareholding structure of Financière de Tubize SA is available here

Shareholder Structure

Source

Latest notifications and shareholder identification (as of May 2024), UCB underlying ownership analysis

close

62% Free Float

Institutional investors:
Geographic distribution

Shareholders' Meetings

The Ordinary General Meeting of Shareholders is held on the last Thursday of April at 11:00 CET.

Shareholders' Meeting Archives


 


 

Consensus

Estimates based on Visible Alpha consensus1 dated 01.10.2024.

Estimates include 14 broker models2 collaborating with Visible Alpha.

UCB FY Consensus Earnings Estimates (Average)
In € million2023a2024e2025e 2026e2027e2028e2029e
Net Sales4,8675,4646,4237,2238,1188,7739,286
Revenue5,2525,7876,7437,5558,4249,0459,527
Adjusted EBIT6577121,3371,8242,3722,6992,973
Adjusted EBITDA1,3491,3772,0512,5463,0723,4143,684
Adj. EBITDA ratio25.7%23.8%30.4%33.7%36.5%37.7%38.7%
Net Profit3434219711,3591,8022,0722,299
Core EPS (€)4.204.167.219.2011.7613.6815.09
 
UCB FY Consensus Product Sales Estimates (Average)
In € million2023a2024e2025e 2026e 2027e 2028e2029e
Product Portfolio      
Cimzia2,0872,0211,9131,7691,6401,3821,175
Bimzelx1485471,2382,0092,8273,5704,161
Evenity*60109151193226257274
Rystiggo 180324465600679737
Zilbrysq 63171293404505577
Vimpat394322266225204183169
Keppra636576531491455417388
Briviact576674750571401305254
Neupro 237188162142126110
Fintepla226340480613727803850
Nayzilam94114132142151149119
Potential New Products non-risk adjusted    
Dapirolizumab pegol  193677126232
Staccato alprazolam 30234867106145
Bepranemab     145315
Minzasolmin     130325
doxTM / MT1621  3855101140171

*European sales, ex-EU sales booked by Amgen/Astellas

 

1Disclaimer

The information provided by Visible Alpha cited herein provided “as is” and “as available” without warranty of any kind. Use of any Visible Alpha data is at your own risk and Visible Alpha disclaims any liability for use of the Visible Alpha data.
Although the information is obtained or compiled from reliable sources Visible Alpha neither can nor does guarantee or make any representation or warranty, either express or implied, as to the accuracy, validity, sequence, timeliness, completeness or continued availability of any information or data, including third-party content, made available herein.
In no event shall Visible Alpha be liable for any decision made or action or inaction taken in reliance on any information or data, including third-party content. Visible Alpha further explicitly disclaims, to the fullest extent permitted by applicable law, any warranty of any kind, whether express or implied, including warranties of merchantability, fitness for a particular purpose and non-infringement.

close

2Contributing brokers

BrokerModel date
BNPP Exane

31-Jul-2024

BofA

24-Jul-2024

Citi

19-Jun-2024

Cowen

25-Jul-2024

Degroof Petercam

27-09-2024

Deutsche Bank

29-Jul-2024

HSBC

02-08-2024

ING

08-08-2024

Jefferies

29-Jul-2024

KBC

14-08-2024

Kepler

20-06-2024

ODDO BHF

26-Jul-2024

Redburn

07-08-2024

UBS

30-Jul-2024

 

close

 

Dividends

The Board intends to continue to sustain a dynamic dividend policy, consistent with the long-term growth prospects of the Company, offering gradual increase in dividend, and as far as possible not to reduce it, irrespective of the short-term income variations.

The Board of Directors proposes to pay a gross dividend of € 1.36 per share (gross), to be approved by the annual general meeting of the shareholders.

  • Coupon # 27
  • Ex-dividend: 26 April 2024
  • Record date: 29 April 2024
  • Payment: 30 April 2024

Coupon # 27 of UCB shares is payable at € 0.952 net per share after deduction of Belgian withholding tax of 30%*, via our paying agent, KBC Bank NV.

* Lower withholding tax rates may be applicable depending on the specific situation of each shareholder.